West Pharmaceutical (WST) PT Raised to $390 at Evercore ISI

April 23, 2026 12:12 PM

Evercore ISI analyst Daniel Markowitz raised the price target on West Pharmaceutical (NYSE: WST) to $390.00 (from $320.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found